These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28640323)

  • 1. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
    Wu C; Stafford AR; Fredenburgh JC; Weitz JI; Gils A; Declerck PJ; Kim PY
    Thromb Haemost; 2017 Jul; 117(8):1509-1517. PubMed ID: 28640323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
    Wu C; Kim PY; Manuel R; Seto M; Whitlow M; Nagashima M; Morser J; Gils A; Declerck P; Nesheim ME
    J Biol Chem; 2009 Mar; 284(11):7059-67. PubMed ID: 19074424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT; Boffa MB
    J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L; Nesheim M; Morser J; Tracy PB
    J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells.
    Wu C; Kim PY; Swystun LL; Liaw PC; Weitz JI
    J Thromb Haemost; 2016 Feb; 14(2):366-74. PubMed ID: 26663133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
    Schneider M; Nagashima M; Knappe S; Zhao L; Morser J; Nesheim M
    J Biol Chem; 2002 Mar; 277(12):9944-51. PubMed ID: 11786552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
    Schneider M; Boffa M; Stewart R; Rahman M; Koschinsky M; Nesheim M
    J Biol Chem; 2002 Jan; 277(2):1021-30. PubMed ID: 11684677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO
    J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains.
    Hall SW; Nagashima M; Zhao L; Morser J; Leung LL
    J Biol Chem; 1999 Sep; 274(36):25510-6. PubMed ID: 10464282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
    Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
    Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation.
    Incampo F; Carrieri C; Semeraro N; Colucci M
    Thromb Res; 2014 Nov; 134(5):1110-6. PubMed ID: 25193406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
    van Moorsel MVA; Poolen GC; Koekman CA; Verhoef S; de Maat S; Barendrecht A; van Kleef ND; Meijers JCM; Schiffelers RM; Maas C; Urbanus RT
    J Thromb Haemost; 2022 May; 20(5):1213-1222. PubMed ID: 35170225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
    Boffa MB; Wang W; Bajzar L; Nesheim ME
    J Biol Chem; 1998 Jan; 273(4):2127-35. PubMed ID: 9442053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis.
    Mochizuki L; Sano H; Honkura N; Masumoto K; Urano T; Suzuki Y
    Thromb Haemost; 2023 Jan; 123(1):16-26. PubMed ID: 36307100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.
    Binette TM; Taylor FB; Peer G; Bajzar L
    Blood; 2007 Nov; 110(9):3168-75. PubMed ID: 17644733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.
    Wang W; Nagashima M; Schneider M; Morser J; Nesheim M
    J Biol Chem; 2000 Jul; 275(30):22942-7. PubMed ID: 10801821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for arginine-12 in thrombin-thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor.
    Plug T; Kramer G; Meijers JC
    J Thromb Haemost; 2014 Oct; 12(10):1717-25. PubMed ID: 25066897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new pedigree with thrombomodulin-associated coagulopathy in which delayed fibrinolysis is partially attenuated by co-inherited TAFI deficiency.
    Westbury SK; Whyte CS; Stephens J; Downes K; Turro E; Claesen K; Mertens JC; Hendriks D; Latif AL; Leishman EJ; ; Mutch NJ; Tait RC; Mumford AD
    J Thromb Haemost; 2020 Sep; 18(9):2209-2214. PubMed ID: 32634856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.